Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: The Rancho Bernardo study

Journal of the American Geriatrics Society

Volumn 47, Issue 6, 1999, Pages 685-691

  Barrett Connor, Elizabeth ^b   Von Mühlen, Denise ^c   Laughlin, Gail A ^c   Kripke, Adrianna ^a  

^a HARVARD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE

Author keywords

Aging; Depression; DHEAS; Mood; Sex hormones

Indexed keywords

PRASTERONE; PRASTERONE SULFATE; SEX HORMONE; STEROID;

ADULT; AGED; AGING; ARTICLE; CIGARETTE SMOKING; DEPRESSION; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; MENOPAUSE; MOOD; PHYSICAL ACTIVITY; POPULATION RESEARCH; POSTMENOPAUSE; RADIOIMMUNOASSAY; SITTING; TESTOSTERONE BLOOD LEVEL; WEIGHT REDUCTION;

EID: 0344603632     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1999.tb01590.x     Document Type: Article

References (78)

1. Depression Guideline Panel. 1993. Depression in Primary Care: Volume 1, Direction and Diagnosis. Rockville, MD: U.S. Department of Health and Human Services, p. 23.
2. McKinlay JB, McKinlay SM, Brambilla D. The relative contributions of endocrine changes and social circumstances to depression in mid-aged women. J Health Soc Behav 1987;28:345-63.
3. Hunter MS. Psychological and somatic experience of the menopause: A prospective study. Psychosom Med 1990;52:357-367.
4. Stewart DE, Boydell K, Derzko C, Marshall V. Psychological distress during the menopausal years in women attending a menopause clinic. Int J Psychiatry Med 1992;22:213-220.
5. Avis NE, Brambilla D, McKinlay SM, Vass K. A longitudinal analysis of the association between menopause and depression. Ann Epidemiol 1994;4:214-220.
6. Sichel DA, Cohen LS, Robertson LM et al. Prophylactic estrogen in recurrent postpartum affective disorder. Biol Psychiatry 1995;38:814-818.
7. Gregoire AJP, Kumar R, Everitt B et al. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996;347:930-933.
8. Magos AL, Brincat M, Studd JWW. Treatment of premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone: A model for the premenstrual syndrome. BMJ 1986;292:1629-1633.
9. Watson NR, Studd JWW, Garnet T, Baker RJ. A randomised placebo controlled study of transdermal oestradiol patches for the treatment of premenstrual syndrome. Lancet 1989;ii:730-732.
10. Montgomery JC, Appleby L, Brincat M et al. Effect of oestrogen and testosterone implants of psychological disorders in the climacteric. Lancet 1987;1: 297-299.
11. Sherwin BB. Sex hormones and psychological functioning in postmenopausal women. Exp Gerontol 1994;29:423-430.
12. Coope J. Hormonal and non-hormonal interventions for menopausal symptoms. Maturitas 1996;23:159-168.
13. Ditkoff EC, Crary WG, Christo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991;78:991-995.
14. Saletu B, Brandstätter N, Metka M et al. Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression. Psychopharmacology 1995;122:321-329.
15. Fink G, Sumner BE, Rosie R et al. Estrogen control of central neurotransmission: Effect on mood, mental state, and memory. Cell Mol Neurobiol 1996;16:325-344.
16. Sherwin BB. Hormones, mood, and cognitive functioning in postmenopausal women. Obstet Gynecol 1996 87(2 Suppl):20-26S.
17. Klaiber EL, Broverman DM, Vogel W et al. Relationships of serum estradiol levels, menopausal duration, and mood during hormonal replacement therapy. Psychoneurocndocrinology 1997;22:549-558.
18. Pearlstein TB. Hormones and depression: What are the facts about premenstrual syndrome, menopause, and hormone replacement therapy? Am J Obstet Gynecol 1995;173:646-653.
19. Naftolin F, Ryan KJ. The metabolism of androgen in central neuroendocrine tissues. J Steroid Biochem 1975;6:993-997.
20. Robel P, Baulieu E-E. Dehydroepiandrosterone (DHEA) is a neuroactive neurosteroid. Ann N Y Acad Sci 1995;774:82-110.
21. Brincat M, Magos A, Studd JWW et al. Subcutaneous hormone implants for the control of climacteric symptoms: A prospective study. Lancet 1984;1: 16-18.
22. Sherwin BB, Gelfland MM. Sex steroids and affect in the surgical menopause: A double-blind, cross-over study. Psychoneuroendocrinology 1985; 10:325-335.
23. Sherwin BB. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord 1988;14:177-187.
24. Morales AJ, Nolan JJ, Nelson JC, Yen SSC. Effects of replacement dose of DHEA in men and women of advancing age. J Clin Endocrinol Metab 1994; 78:1360.
25. Wolkowitz OM, Reus VI, Roberts E et al. Antidepressant and cognitionenhancing effects of DHEA in major depression. Ann N Y Acad Sci 1995; 477:337-339.
26. Wolf OT, Neumann O, Hellhammer DH et al. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J Clin Endocrinol Metab 1997;82:2363-2367.
27. Kudielka BM, Hellhammer J, Hellhammer DH et al. Sex differences in endocrine and psychological responses to psychosocial stress in healthy elderly subjects and the impact of a 2-week dehydroepiandrosterone treatment. J Clin Endocrinol Metab 1998;83:1756-1761.
28. Maes M, Van Gastel A, Ranjan R et al. Stimulatory effects of L-5-hydroxytrytophan on postdexamethasone beta-endorphin levels in major depression. Neuropsychopharmacology 1996;15:340-348.
29. Maes M, Van Gastel A, Blockx P et al. Lower serum transcortin (CBG) in major depressed females: Relationships with baseline and postdexamethasone cortisol values. J Affect Disord 1996;38:47-56.
30. Rubin RT, Phillips JJ, McCracken JT, Sadow TF. Adrenal gland volume in major depression: Relationship to basal and stimulated pituitary-adrenal cortical axis function. Biol Psychiatry 1996;40:89-97.
31. Mortola JF, Liu JH, Rasmussen DD, Yen SSC. Pulsatile rhythms of adrenocorticotropin (ACTH) and cortisol in women with endogenous depression: Evidence for increased ACTH pulse frequency. J Clin Endocrinol Metab 1987;65:962-968.
32. Gold PW, Loriaux DL, Roy A et al. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease: Pathophysiologic and diagnostic implications. N Engl J Med 1986;314:1329-1335.
33. Ballinger CB, Browning MCK, Smith AHW. Hormone profiles and psychological symptoms in peri-menopausal women. Maturitas 1987;9:235-251.
34. Cawood EH, Bancroft J. Steroid hormones, the menopause, sexuality and well-being of women. Psychol Med 1996;26:925-936.
35. Berr C, Lafont S, Baulieu E-E et al. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: A French community-based study. Proc Natl Acad Sci USA 1996;93:13410-13415.
36. Yaffe K, Ettinger B, Pressman A et al. Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: A prospective study. Biol Psychiatry 1998;43:694-700.
37. Beck AT, Ward CH, Mendelson M et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
38. Shrout PE, Yager TJ. Reliability and validity of screening scales: Effect of reducing scale length. J Clin Epidemiol 1989;42:69-78.
39. Gallagher D, Nies G, Thompson LW. Reliability of the Beck Depression Inventory with older adults. J Consult Clin Psychol 1982;50:152-153.
40. Reynolds WM, Gould JW. A psychometric investigation of the standard and short form Beck Depression Inventory. J Consult Clin Psychol 1981;49:306-307.
41. Rosner W. A simplified method for the quantitative determination of testosterone-estradiol-binding globulin activity in human plasma. J Clin Endocrinol Metab 1972;34:983-988.
42. Tremblay RR, Dube JY. Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. Contraception 1974;10:599-605.
43. Bolelli G, Muti P, Micheli A et al. Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma. Cancer Epidemiol Biomarkers Prev 1995;4:509-513.
44. Barrett-Connor E, Goodman-Gruen D. The epidemiology of DHEAS and cardiovascular disease. Ann N Y Acad Sci 1995;774:259-270.
45. Barrett-Connor E, Ferrara A. Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study. J Clin Endocrinol Metab 1996;81:59-64.
46. Barrett-Connor E, Goodman-Gruen D. Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women: The Rancho Bernardo Study. Circulation 1995;91:1757-1760.
47. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984;59:551-555.
48. Murrell SA, Himmelfarb S, Wright K. Prevalence of depression and its correlates in older adults Am J Epidemiol 1983;117:173-185.
49. Rotter JI, Wong L, Lifrak ET, Parker LN. A genetic component to the variation of dehydroepiandrosterone sulfate. Metabolism 1985;34:731-736.
50. Orentreich N, Brind JL, Vogelman JH et al. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab. 1992 75;1002-1004.
51. Thomas G, Frenoy N, Legrain S et al. Debuire B. Serum dehydroepiandrosterone sulfate levels as an individual marker. J Clin Endocrinol Metab 1994; 79:1273-1276.
52. Goodyer IM, Herbert J, Altham PM et al. Adrenal secretion during major depression in 8- to 16- year olds, I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychol Med 1996;26:245-256.
53. Balieu EE. Dehydroepiandrosterone (DHEA). A Fountain of Youth? J Clin Endocrinol Metab 1996;81:3147-3151.
54. Guazzo EP, Kirkpatrick PJ, Goodyer IM et al. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man relation to blood levels and the effects of age. J Clin Endocrinol Metab 1996;81:3951-60.
55. Wright BE, Porter JR, Browne E, Svec F. Antiglucocorticoid action of dehydroepiandrosterone in young obese Zucker rats. Int J Obesity 1991;16:579-593.
56. May M, Holmes E, Rogers W, Poth M. Protection from glucocorticoid induced thymic involution by dehydroepiandrosterone. Life Sci 1991;46:1627-1631.
57. Sapolsky RM. Why stress is bad for your brain. Science 1996;273:749-750.
58. Kimonides VG, Khatibi NH, Svendsen CN et al. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci USA 1998; 95:1852-1857.
59. Glaser JL, Brind JL, Vogelman JH et al. Elevated serum dehydroepiandrosterone sulfate levels in practitioners of the Transcendental Meditation (TM) and TM-Sidhi programs. J Behav Med 1992;15:327-341.
60. Labbate LA, Fava M, Oleshansky M et al. Physical fitness and perceived stress. Relationships with coronary artery disease risk factors. Psychosomatics 1995;36:555-560.
61. Littman AB, Fava M, Halperin P et al. Physiologic benefits of a stress reduction program for healthy middle-aged Army officers. J Psychosom Res 1993; 37:345-354.
62. McCraty R, Barrios-Choplin B, Rozman D et al. The impact of a new emotional self-management program on stress, emotions, heart rate variability, DHEA and cortisol. Integr Physiol Behav Sci 1998;33:151-170.
63. Avis NE, McKinlay SM, Vass K, Brambilla D. Hormone levels, Symptoms, and the Relation Between Menopause and Depression. Paper presented at the 7th annual International Congress on the Menopause. Stockholm, Sweden, 1993.
64. Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 1991;72:336-343.
65. Magos Al, Brewster E, Singh R et al. The effects of norethisterone in postmenopausal women on estrogen replacement therapy: A model for the premenstrual syndrome. Br J Obstet Gynecol 1986;93:1290-1296.
66. Liu H, Laughlin GA, Fischer UG, Yen SSC. Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: Evidence for a reduced 17,20-desmolase enzymatic activity. J Clin Endocrinol Metab 1990;71:900-906.
67. Van Cauter E, Leproult R, Kupfer DJ. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 1996; 81:2468-2473.
68. Hankinson SE, Manson JE, Spiegelman D et al. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3 year period. Cancer Epidemiol Biomarkers Prev 1995;4:649-654.
69. Cauley JA, Gutai JP, Kuller LH et al. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989;129:1120-1131.
70. Pfeilschifter J, Scheid-Nave C, Leidig-Bruckner G et al. Relationship between circulating insulin-like growth factor components and sex hormones in a population-based study of 50- to 80-year-old men and women. J Clin Endocrinol Metab 1996;81:2534-2540.
71. Kley HK, Schlaghecke R, Kruskemper HL. Stability of steroids in plasma over a 10-year period. J Clin Chem Clin Biochem 1985;23:875-878.
72. Farmer ME, Locke BZ, Moscicki EK et al. Physical activity and depressive symptoms: The NHANES I epidemiologic follow-up study. Am J Epidemiol 1988;128:1340-1351.
73. DiPietro L, Anda RF, Williamson DF, Stunkard AJ. Depressive symptoms and weight change in a national cohort of adults. Int J Obes Relat Metab Disord 1992;16:745-753.
74. Barefoot JC, Heitmann BL, Helms MJ et al. Symptoms of depression and changes in body weight from adolescence to mid-life. Int J Obes Relat Metab Disord 1998;22:688-694.
75. NIH Consensus Conference. Diagnosis and treatment of depression in late life. JAMA 1992;268:1018-1024.
76. Hollingshead AB. Two Factor Index of Social Position. Privately published, 1957.
77. Eaton WW, Kessler LG. Rates of symptoms of depression in a national sample. Am J Epidemiol 1981;114:528-538.
78. Palinkas LA, Barrett-Connor E. Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol 1992;80:30-36.-